An interventional study of Multimodal Pain Management Program and Usual Primary Care in Chronic Musculoskeletal Pain, sponsored by Universitat Jaume I. Not yet recruiting at 5 sites in Spain. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-03-10.
Sponsored by Universitat Jaume I · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 597 studies in Motor Activity with a site in Spain — 148 open to participants now, 184 under way, 1 of them phase 3. Motor Activity · Spain.
Among the 597 studies in Motor Activity with a site in Spain, this one is the 144th largest by planned enrollment of the 539 interventional ones that give a count, is one of 66 that started in 2026, is one of 515 with no phase, reaches primary completion later than 168 of the 183 other live ones, and was the 537th registered.
9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.
Browse Motor Activity studies →148 of the 597 studies in Motor Activity with a site in Spain are open now. Recruiting first, the newest first:
Universidad Pública de Navarra · Sites in Spain
Ages 65+
University of Valencia · Sites in Spain
Ages 60–99
Universidad San Jorge · Sites in Spain
Ages 18–65 · Healthy volunteers
Institut Investigacio Sanitaria Pere Virgili · Sites in Spain
Ages 18+ · Women only
Alberto Bermejo Franco · Sites in Spain
Ages 70+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
597 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 12 · Phase 3 9 · Phase 4 4
First in 2004; this study’s year is marked. 66 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 146 is above the median of 60 across 8,412 interventional studies indexed under Motor Activity.
Median enrollment 80 across the 539 interventional studies, 145 across the 58 observational. Of the 335 that completed or were terminated, 5 (1%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 597 have an industry lead sponsor. The 10 most frequent:
Universitat Jaume I is the lead sponsor of 80 studies on the registry; 19 are open to participants now.
Universitat Jaume I has 5 studies filed under Motor Activity — fewer than ten, so there is no comparison to draw.
47 of the studies in Motor Activity with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07183241Universidad Pública de NavarraHospital-to-Home Rehabilitation Through Exercise and Cognitive Training | 2026-12 |
| NCT07489391University of DeustoConcomitant Use of Radiotherapy and Integrated Exercise - Lung Cancer | 2026-12 |
| NCT07232511University of ValenciaExercise-induced Hypoalgesia Effects of Blood Flow Restriction in People With Rotator Cuff-related Shoulder Pain | 2026-12 |
| NCT06446596University of ValenciaTelerehabilitation-based Exercises vs Standard Home-based Exercise in Low Back Pain | 2026-12 |
| NCT06948500Cardenal Herrera UniversityEffectiveness of an IVR-based Therapeutic Exercise Program With Altered Visual Feedback in Fibromyalgia Patients | 2026-12-01 |
Add all 47 to your calendar (.ics) → With an account.
Among the 597 studies in Motor Activity with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This multicenter randomized controlled trial aims to evaluate the effectiveness of a multimodal intervention for the active management of persistent musculoskeletal pain in primary care. The intervention combines pain neuroscience education, therapeutic exercise, and the promotion of self-care and healthy lifestyle habits to improve health-related quality of life in adults with persistent nonspecific musculoskeletal pain lasting at least six months.
A total of 146 participants aged 18 to 70 years will be recruited from five primary care centers in the Comunitat Valenciana (Spain) and randomly assigned to either the experimental group or the control group. The primary outcome is health-related quality of life measured using the SF-36 Health Survey. Secondary outcomes include pain intensity, pain catastrophizing, kinesiophobia, central sensitization, emotional symptoms, perceived social support, medication use, and lifestyle-related variables. Assessments will be conducted at baseline, post-intervention, 6 months, and 12 months follow-up.
Persistent musculoskeletal pain represents a major public health problem and is one of the most frequent reasons for consultation in primary care. It is associated with reduced quality of life, functional limitations, emotional distress, increased healthcare utilization, and high socioeconomic costs. Contemporary pain science recognizes that persistent pain is a multidimensional experience involving biological, psychological, and social mechanisms, including central sensitization and maladaptive cognitive-emotional processes such as catastrophizing and fear-avoidance behaviors.
Current clinical practice guidelines recommend multimodal and non-pharmacological approaches as first-line management strategies. Pain neuroscience education (PNE) aims to reconceptualize pain by explaining the neurobiological and psychosocial mechanisms involved in persistent pain, thereby reducing perceived threat and maladaptive beliefs. Therapeutic exercise contributes to functional improvement, modulation of central pain mechanisms, and psychological well-being. Additionally, the promotion of self-care strategies and healthy lifestyle habits (including physical activity, sleep hygiene, stress management, and nutritional counseling) may enhance long-term outcomes and patient empowerment.
This study is a multicenter, parallel-group, single-blind randomized controlled trial conducted in five primary care centers in the Comunitat Valenciana (Spain). A total of 146 adults aged 18 to 70 years with nonspecific persistent musculoskeletal pain lasting at least six months will be recruited and randomly allocated to either an experimental group receiving the multimodal intervention or a control group receiving usual care.
The multimodal intervention integrates structured group-based pain neuroscience education sessions, supervised therapeutic exercise, and guidance on self-care and healthy lifestyle habits. The control group will continue to receive standard primary care management.
The primary outcome is health-related quality of life assessed using the SF-36 Health Survey. Secondary outcomes include pain intensity, number of painful areas, pain catastrophizing, kinesiophobia, central sensitization, emotional symptoms, perceived social support, medication consumption, and lifestyle-related variables. Data will be collected at baseline, immediately post-intervention, and at 6- and 12-month follow-ups using the REDCap electronic data capture system.
Statistical analyses will include descriptive statistics and inferential analyses to compare within- and between-group differences over time. The study aims to provide robust evidence regarding the effectiveness of a multimodal, biopsychosocial intervention delivered in primary care for the management of persistent musculoskeletal pain.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants assigned to the experimental group will receive a structured multimodal intervention delivered in primary care settings. The intervention integrates group-based pain neuroscience education sessions, supervised therapeutic exercise, and guidance on self-care strategies and healthy lifestyle habits. The program aims to promote active coping, improve functional capacity, and enhance health-related quality of life in individuals with persistent musculoskeletal pain.
Behavioral: Multimodal Pain Management Program
Participants assigned to the control group will receive usual primary care management for persistent musculoskeletal pain. Usual care may include pharmacological treatment, medical follow-up, and referral to other healthcare services when considered necessary, according to standard clinical practice.
Other: Usual Primary Care
The multimodal program combines pain neuroscience education, therapeutic exercise, and the promotion of self-care and healthy lifestyle habits. Pain neuroscience education focuses on reconceptualizing pain based on contemporary neurophysiological principles. Therapeutic exercise includes supervised physical activity aimed at improving strength, mobility, and functional capacity. The self-care component addresses lifestyle factors such as physical activity, sleep hygiene, stress management, and healthy nutrition.
Participants in the control group will continue receiving standard primary care treatment as determined by their healthcare providers. This may include medication, medical advice, or referral to other services according to routine clinical practice.
Health-Related Quality of Life
Health-related quality of life assessed using the 36-Item Short Form Health Survey (SF-36). The SF-36 measures eight health domains and provides physical and mental component summary scores. Higher scores indicate better health-related quality of life.
Time frame: Baseline, immediately post-intervention, 6 months, and 12 months after intervention
Pain Intensity
Pain intensity measured using a numerical rating scale (NRS), where higher scores indicate greater pain intensity.
Time frame: Baseline, immediately post-intervention, 6 months, and 12 months after intervention
Number of Painful Body Areas
Number of body areas with reported pain as self-identified by participants.
Time frame: Baseline, immediately post-intervention, 6 months, and 12 months after intervention
Pain Catastrophizing
Pain catastrophizing assessed using the Pain Catastrophizing Scale (PCS). Higher scores indicate greater catastrophizing.
Time frame: Baseline, immediately post-intervention, 6 months, and 12 months after intervention
Kinesiophobia
Fear of movement assessed using the Tampa Scale of Kinesiophobia (TSK). Higher scores indicate greater fear of movement.
Time frame: Baseline, immediately post-intervention, 6 months, and 12 months after intervention
Central Sensitization
Central sensitization symptoms assessed using the Central Sensitization Inventory (CSI). Higher scores indicate greater symptom severity.
Time frame: Baseline, immediately post-intervention, 6 months, and 12 months after intervention
Anxiety Symptoms
Anxiety symptoms assessed using the Overall Anxiety Severity and Impairment Scale (OASIS). The OASIS is a 5-item self-report questionnaire measuring the frequency and severity of anxiety symptoms and related functional impairment. Scores range from 0 to 20, with higher scores indicating greater anxiety severity.
Time frame: Baseline, immediately post-intervention, 6 months, and 12 months after intervention
Depressive Symptoms
Depressive symptoms assessed using the Overall Depression Severity and Impairment Scale (ODSIS). The ODSIS is a 5-item self-report questionnaire assessing the frequency and severity of depressive symptoms and associated impairment. Scores range from 0 to 20, with higher scores indicating greater depressive symptom severity.
Time frame: Baseline, immediately post-intervention, 6 months, and 12 months after intervention
Perceived Social Support
Perceived social support assessed using the Duke-UNC Functional Social Support Questionnaire (DUKE-UNC-11). The questionnaire evaluates perceived emotional and instrumental social support. Scores range from 11 to 55, with higher scores indicating greater perceived social support.
Time frame: Baseline, immediately post-intervention, 6 months, and 12 months after intervention
Medication Consumption
Changes in the number and type of medications used for pain management.
Time frame: Baseline, immediately post-intervention, 6 months, and 12 months after intervention
Participant Satisfaction With the Intervention
Participant satisfaction assessed using the Client Satisfaction Questionnaire-8 (CSQ-8), an 8-item self-report instrument measuring satisfaction with healthcare services. Total scores range from 8 to 32, with higher scores indicating greater satisfaction with the intervention.
Time frame: Immediately post-intervention
Plan to share: Yes — De-identified individual participant data (IPD) underlying the results reported in publications will be made available upon reasonable request. Data will be shared after publication of the primary results and will include variables necessary to reproduce the analyses. All shared data will be fully anonymized in accordance with applicable data protection regulations (including GDPR). Requests must include a methodologically sound research proposal and will require approval by the principal investigator and the corresponding ethics committee where applicable.
Supporting information: Study protocol
Start is estimated for Jun 2026; primary completion for Jan 2028, 19 months later.
Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 19 months is above that.
Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitat Jaume I